<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1435</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2024-32-1-75-82</article-id><article-categories><subj-group subj-group-type="heading"><subject>Неопределен</subject></subj-group></article-categories><title-group><article-title>The experience of organization of combined screening of uterine neck cancer in the Republic of Bashkortostan</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Olkhov</surname><given-names>Ilya Gennadievich</given-names></name><email>info@bfrazvitie.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grishina</surname><given-names>Natalya Konstantinovna</given-names></name><email>uch_secret@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Timurzieva</surname><given-names>Alina Borisovna</given-names></name><email>alinko9977z@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia</aff><pub-date date-type="epub" iso-8601-date="2024-02-11" publication-format="electronic"><day>11</day><month>02</month><year>2024</year></pub-date><volume>32</volume><issue>1</issue><history><pub-date date-type="received" iso-8601-date="2025-04-19"><day>19</day><month>04</month><year>2025</year></pub-date><pub-date date-type="accepted" iso-8601-date="2025-04-19"><day>19</day><month>04</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 2025,</copyright-statement><copyright-year>2025</copyright-year></permissions><abstract>&lt;p&gt;The article considers organizational issues of cervical cancer screening in the Russian Federation. In particular, experience of implementation of the Project HPV testing within the framework of combined cervical cancer screening (HPV and cytologic screening) in the Republic of Bashkortostan is considered. The cervical cancer is a widespread disease that requires early diagnosis and timely medical care. The main aspects of organization of medical care of patients with gynecological diseases in relevant normative legal regulatory documents are described. The algorithm and scheme of routing patients with suspected cervical cancer and with this disease are presented.&lt;br /&gt;The study covered more than 60,000 women aged 3039 years from 14 medical organizations of Ufa. Such methods as sociological, statistical, analytical, content-analysis and organizational experiment were applied.&lt;br /&gt;The study permitted to substantiate and to approve both the Project HPV testing as part of combined screening for cervical cancer (HPV screening and cytologic screening) and the algorithm of combined screening of cervical cancer during preventive examinations of female adult population aged 3039 years of the Republic of Bashkortostan. The scheme was developed for routing patients with suspected cervical cancer or diagnosed disease to medical organizations for timely medical care support.&lt;br /&gt;By implementing developed routing and screening scheme for patients at risk of developing cervical cancer, as well as those who already suffer this pathology, it is possible to improve quality of organization and delivery of medical care, to reduce morbidity, mortality and disability because of this pathology and to assure early diagnosis and prevention of cervical cancer.&lt;/p&gt;</abstract><kwd-group xml:lang="en"><kwd>cervical cancer</kwd><kwd>screening</kwd><kwd>early diagnosis</kwd><kwd>preventive examination</kwd><kwd>quality</kwd><kwd>medical care</kwd><kwd>prevention</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак шейки матки</kwd><kwd>скрининг</kwd><kwd>ранняя диагностика</kwd><kwd>профилактический осмотр</kwd><kwd>качество оказания медицинской помощи</kwd><kwd>профилактика</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Arbyn M., Weiderpass E., Bruni L. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob. Health. 2020;8:e191–203.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Solopova A., Idrisova L., Surenkov A., et al. Epidemiology of cervical cancer in the aspect of medical rehabilitation of gynecological cancer patients. Doctor. 2018;29(2):26–30. doi: 10.29296/25877305-2018-02-06 (in Russian).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Formigosa L. A. C., Dos Santos L. F., Formigosa J. D. C., da Silva Pinto D., Dos Reis D. S. T., da Silva M. V. S. Impact of screening on cervical cancer incidence and mortality in a Northern Brazilian city. Еcancer. 2022;16:1418. doi: 10.3332/ecancer.2022.1418.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Connon S. R. D., Soyunov M. A. Cervical cancer: prevention and screening (new data). Akusherstvo i ginekologiya: Novosti. Mneniya. Obucheniya = Obstetrics and Gynecology: news, opinions, training. 2018;6(3):72–82 (in Russian).</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Simms K. T., Steinberg J., Caruana M., Smith M. A., Lew J. B., Soerjomataram I., Castle P. E., Bray F., Canfell K. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. Lancet Oncol. 2019;20:394–407. doi: 10.1016/S1470-2045(18)30836-2</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Flanagan M. B. Primary high-risk human papillomavirus testing for cervical cancer screening in the United States: is it Journal of Oncology 11 time? Arch. Pathol. Lab. Med. 2018;42(6):688–92.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Bedell S. L., Goldstein L. S., Goldstein A. R., Goldstein A. T. Cervical Cancer Screening: Past, Present, and Future. Sex Med. Rev. 2020;8(1):28–37. doi: 10.1016/j.sxmr.2019.09.005</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kessler T. A. Cervical Cancer: Prevention and Early Detection. Semin. Oncol. Nurs. 2017;33(2):172–83. doi: 10.1016/j.soncn.2017.02.005</mixed-citation></ref></ref-list></back></article>
